Abstract
65P Durvalumab combined with chemotherapy and radiotherapy in patients with oligometastatic non-small cell lung cancer (SABRcure)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.esmoop.2024.102644
Journal: ESMO Open | Publication Date: Mar 1, 2024 |
License type: cc-by-nc-nd |
65P Durvalumab combined with chemotherapy and radiotherapy in patients with oligometastatic non-small cell lung cancer (SABRcure)
Join us for a 30 min session where you can share your feedback and ask us any queries you have